Literature DB >> 11941979

Limits and benefits of exclusive transthoracic hepatectomy approach for patients with hepatocellular carcinoma.

Marc Pocard1, Alain Sauvanet, Jean-Marc Regimbeau, Olivier Duwat, Olivier Farges, Jacques Belghiti.   

Abstract

BACKGROUND/AIMS: The purpose of this study was to evaluate the results of liver resection in cirrhotic patients for liver hepatocellular carcinoma located near the diaphragm through an exclusive transthoracic approach.
METHODOLOGY: Between 1995 and 1999, 19 cirrhotic patients with hepatocellular carcinoma underwent a liver resection through an exclusive transthoracic approach. This approach was indicated in 11 cases for previous upper abdominal surgery, including hepatobiliary surgery in 3 and before liver transplantation in 8. Results of the transthoracic approach were compared to 84 cirrhotic patients who underwent transabdominal limited resection of hepatocellular carcinoma matched for age, sex and localization of the tumor.
RESULTS: Resection was feasible by an exclusive transthoracic approach in 18 (95%) cases with a mean operating time of 201 +/- 53 min. In 8 (44%) patients a Pringle maneuver was performed. No postoperative deaths were observed after the transthoracic approach. Pulmonary complications rate was significantly higher (P < 0.001) after transthoracic resection compared to transabdominal resection (67% vs. 25%, P < 0.001). In contrast, ascites were observed in only one (5%) of the transthoracic group compared to 35 (42%) in the transabdominal group (P < 0.01). The resection margin was positive in 3 (17%) after transthoracic approch and in 1 (2%) patient after the transabdominal resection (P < 0.02). In patients who underwent liver transplantation after the transthoracic approach, total hepatectomy was performed without increasing difficulties.
CONCLUSIONS: The transthoracic approach is a safe procedure for resection of hepatocellular carcinoma located under the right diaphragm in cirrhotic patients. However, this approach allows only limited resection with a high risk of positive margin, resulting in a restriction of indications either for patients with previous major abdominal surgery than before liver transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 11941979

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

Review 1.  Thoracoabdominal approach in liver surgery: how, when, and why.

Authors:  Matteo Donadon; Guido Costa; Andrea Gatti; Guido Torzilli
Journal:  Updates Surg       Date:  2013-12-12

2.  Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases.

Authors:  Yoshihiro Mise; Reza J Mehran; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2014-06-20       Impact factor: 3.982

3.  Laparoscopic transthoracic liver resection.

Authors:  Jaime Arthur Pirola Krüger; Fabrício Ferreira Coelho; Marcos Vinícius Perini; Paulo Herman
Journal:  Arq Bras Cir Dig       Date:  2014 Nov-Dec

4.  Validation of biological and clinical outcome between with and without thoracotomy in liver resection: a matched cohort study.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Masamichi Moriguchi; Shunji Okada; Yuki Hayashi; Hisashi Nakayama; Tokio Higaki; Masahiko Sugitani
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 5.  HCC: current surgical treatment concepts.

Authors:  F Cauchy; D Fuks; J Belghiti
Journal:  Langenbecks Arch Surg       Date:  2012-06       Impact factor: 3.445

6.  Resection and liver transplantation for HCC.

Authors:  Jacques Belghiti
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

7.  Resection prior to liver transplantation for hepatocellular carcinoma.

Authors:  Jacques Belghiti; Alexandre Cortes; Eddie K Abdalla; Jean-Marc Régimbeau; Kurumboor Prakash; François Durand; Daniele Sommacale; Federica Dondero; Mickael Lesurtel; Alain Sauvanet; Olivier Farges; Reza Kianmanesh
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

8.  Surgical treatment of hepatocellular carcinoma.

Authors:  Jacques Belghiti; Reza Kianmanesh
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

9.  Impact of surgery on quality of life in patients with hepatocellular carcinoma.

Authors:  Yoshihiro Mise; Shouichi Satou; Takeaki Ishizawa; Junichi Kaneko; Taku Aoki; Kiyoshi Hasegawa; Yasuhiko Sugawara; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.